Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ann Oncol ; 23(4): 882-90, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21788360

RESUMO

BACKGROUND: In premenopausal women with hormone receptor-positive breast cancer (BC), 5 years of tamoxifen is recommended. Little is known about reasons for interruption in this population. The aim was to estimate the incidence of tamoxifen interruption and its correlates among younger women. PATIENTS AND METHODS: Using a prospective cohort Elippse 40 of women with BC aged ≤ 40 diagnosed between 2005 and 2008, we studied 196 women. Tamoxifen interruption was defined as two or more consecutive months without dispensed prescription of tamoxifen, based on pharmacy refill database. Two periods were studied: between tamoxifen initiation and 16 months after BC diagnosis, and between 16 and 28 months. RESULTS: Among women treated with tamoxifen, 42% interrupted within the first 2 years of treatment. During the first period, treatment interruptions were associated with a lack of understandable information about endocrine treatment and insufficient social support. During the second period, another set of factors were associated with interruption: treatment side-effects, no longer fearing cancer relapse, lack of social support, no opportunity to ask questions at the time of diagnosis, and fewer treatment modalities. CONCLUSIONS: Improving information and patient-provider relationship might prevent interruption. Particular attention should be paid to women with little social support.


Assuntos
Antineoplásicos Hormonais/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Adesão à Medicação , Tamoxifeno/uso terapêutico , Adulto , Inibidores da Aromatase/uso terapêutico , Quimioterapia Adjuvante , Prescrições de Medicamentos , Substituição de Medicamentos , Feminino , Humanos , Estudos Prospectivos , Autorrelato
2.
Rev Stomatol Chir Maxillofac ; 91(3): 216-8, 1990.
Artigo em Francês | MEDLINE | ID: mdl-2343269

RESUMO

Delayed autotransfusion has been recommended for orthognathic surgery. The authors review and discuss the advantages of this technique. Emphasis is placed on the preventive aspect as it relates to transfusion-associated viral contamination, as well as on the positive implications on health expenditures in the long run. This technique requires excellent intercollaboration on the part of the blood transfusion centers and should definitely be recommended in certain cases of planned surgery. Furthermore, combined with hemodilution methods, it constitutes a very effective means of struggle against edema.


Assuntos
Transfusão de Sangue Autóloga , Procedimentos Cirúrgicos Ortognáticos , Adolescente , Adulto , Idoso , Bancos de Sangue , Transfusão de Sangue Autóloga/economia , Transfusão de Sangue Autóloga/métodos , Transfusão de Sangue Autóloga/estatística & dados numéricos , Feminino , Hematócrito , Hemodiluição , Humanos , Masculino , Pessoa de Meia-Idade , Osteotomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA